View up-to-date information on Gossamer Bio Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 12 Jul 2022 | Gossamer Bio to Raise USD120 Million in Private Placement of Shares | Equity Offering |
New Enterprise Associates Inc
Boxer Capital LLC
EcoR1 Capital LLC
Monashee Investment Management, LLC
Weiss Asset Management LP
Rock Springs Capital Management LP
Madison Avenue Partners LP
Invus LP
|
Gossamer Bio Inc |
| 14 Dec 2020 | Gossamer Bio Inc Enters Phase II/III Clinical Trial Agreement with Optimapharm dd for seralutinib (GDCT0346398) | Contract Service Agreement |
Gossamer Bio Inc
|
Optimapharm dd
|
| 19 Oct 2020 | Gossamer Bio Inc Enters Phase II Clinical Trial Agreement with PSI CRO AG for GB-004 (GDCT0316790) | Contract Service Agreement |
Gossamer Bio Inc
|
PSI CRO AG
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer